Compugen Stock

Compugen Gross Profit

The Gross Profit of Compugen (CGEN) as of Aug 13, 2026 is 63.51 M USD. In the previous year, Gross Profit was 19.93 M USD — a change of 218.62% (higher).

Gross Profit

63.51 MUSD

YoY

218.62%

Last updated:

Gross Profit of Compugen is 2026 63.51 M USD. Gross Profit of Compugen was 2025 19.93 M USD. It decreases by 218.62% higher compared to the previous year.

The Compugen Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

GROSS MARGIN (%)
Date
GROSS MARGIN (%)
Jan 1, 2023
94.01 base
Jan 1, 2024
71.54 base
Jan 1, 2025
87.29 base
Jan 1, 2026 (e)
674.64 base
Jan 1, 2027 (e)
395.77 base
Jan 1, 2028 (e)
205.69 base
Jan 1, 2029 (e)
235.01 base
Jan 1, 2030 (e)
175.87 base
YEARGROSS MARGIN (%)
2030 est 175.87
2029 est 235.01
2028 est 205.69
2027 est 395.77
2026 est 674.64
2025 87.29
2024 71.54
2023 94.01
2022 87.00
2021 88.67
2020 97.00
2019 -
2018 94.19
2017 -
2016 68.68
2015 82.40
2014 72.96
2013 29.30
2012 16.94
2011 200.00
2010 79.91
2009 100.00
2008 97.93
2007 100.00
2006 97.21
Access this data via the Eulerpool API

Compugen Revenue

Compugen Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
33.46 M USD
-12.99 M USD
-18.75 M USD
Jan 1, 2024
27.86 M USD
-14.89 M USD
-14.23 M USD
Jan 1, 2025
72.76 M USD
31.33 M USD
35.34 M USD
Jan 1, 2026 (e)
9.41 M USD
-4.05 M USD
-27.29 M USD
Jan 1, 2027 (e)
16.05 M USD
-6.91 M USD
-26.81 M USD
Jan 1, 2028 (e)
30.88 M USD
-13.29 M USD
-24.77 M USD
Jan 1, 2029 (e)
27.03 M USD
-11.63 M USD
-36.02 M USD
Jan 1, 2030 (e)
36.11 M USD
-15.54 M USD
-29.27 M USD

Compugen Margins

Compugen stock margins

The Compugen margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Compugen. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Compugen.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
94.01 %
-38.83 %
-56.05 %
Jan 1, 2024
71.54 %
-53.44 %
-51.07 %
Jan 1, 2025
87.29 %
43.05 %
48.57 %
Jan 1, 2026 (e)
87.29 %
-43.04 %
-289.82 %
Jan 1, 2027 (e)
87.29 %
-43.05 %
-167.04 %
Jan 1, 2028 (e)
87.29 %
-43.05 %
-80.21 %
Jan 1, 2029 (e)
87.29 %
-43.05 %
-133.30 %
Jan 1, 2030 (e)
87.29 %
-43.05 %
-81.05 %

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Gross Profit of Compugen is 63.51 M USD in 2026.

Gross Profit of Compugen changed from 19.93 M USD to 63.51 M USD, representing a 218.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit Compugen since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's Compugen historically and in real time.

Access this data via the Eulerpool API

Income Statement — Compugen

All Key Metrics — Compugen